Medicine, prevention, nutrition, mental health, healthy aging, health technology, health policy, and the regulation of supplements.
A Japanese trial published in February 2026 found fewer stage II or higher breast cancers after two rounds of mammography plus ultrasound than after mammography alone among women ages 40 to 49. The study did not test breast cancer mortality or establish a routine ultrasound schedule for other ages, risk groups or countries.
A 2025 Science Advances study found that low-dose metformin's glucose-reducing effect in mice depended on a brain Rap1 pathway. The evidence comes from experimental animals, and the parallel for medical AI is limited: a plausible explanation cannot replace external and clinical validation.
England's National Health Service lists bleeding control, water rinsing and clean dressings in guidance last reviewed in April 2026. Deep, gaping, contaminated and bite wounds need medical assessment, as does bleeding that will not stop.
England's NHS, in guidance reviewed in March 2026, advises at least 20 minutes of clean, gentle water flow after a chemical enters an eye. Strong chemicals, sight changes, severe pain and other warning signs require emergency assessment while rinsing continues.
The World Health Organization identifies dehydration as the most severe immediate threat from watery diarrhea. Oral rehydration can replace fluid and electrolytes, while altered alertness, bloody or black stool, severe pain or an inability to keep fluids down require prompt care.
US poison-control specialists recorded 39 suspected amatoxin mushroom poisonings in Northern California between November 2025 and March 2026; four patients died and three needed liver transplants. Because symptoms can start within 30 minutes or remain delayed for more than six hours, suspected wild-mushroom ingestion requires expert advice before illness appears.
The World Health Organization published a new COVID-19 vaccine position paper on July 31, 2026, directing countries to focus routine vaccination on people at the highest risk of severe disease. Previous doses do not settle current eligibility because protection wanes and age thresholds, schedules, products, funding and availability differ by country.
The World Health Organization issued its 2026-2027 northern hemisphere flu vaccine composition recommendation on February 27, 2026, after reviewing global surveillance data. Annual vaccination addresses changing viruses and waning protection, but effectiveness, products and timing vary by season, age, health and country.
WHO designated PQ.16.1.1 a SARS-CoV-2 variant under monitoring on July 27, 2026, after its share of available sequences rose, mainly in the Western Pacific. The agency rated the additional global public health risk as low, while warning that sparse and geographically concentrated evidence limits confidence.
The World Health Organization's 2025 ICOPE handbook places in-depth assessment, care planning, implementation and monitoring after a basic capacity screen. Its pilot data show why services need to record each handoff rather than report only the number of people screened.
Taiwan added PCV21 to its publicly funded adult pneumococcal vaccination program on August 10, 2026, giving eligible people a choice of PCV20 or PCV21. One PCV20 or PCV21 dose completes Taiwan's current program when a dose is due, but previous vaccines, age and risk still determine eligibility and timing.
Taiwan's health ministry launched the National Medical Informatics Certification Laboratory on August 18, 2026. Its three planned tracks cover software, FHIR Box hardware and solution providers, but interoperability tests do not establish clinical safety for medical AI.
The World Health Organization's 2025 ICOPE handbook places capacity checks at the start of a pathway that continues through assessment, a care plan and monitoring. Grip and gait can flag possible decline, but neither measurement establishes a diagnosis or identifies its cause.
WHO's July 2025 position paper recommends herpes zoster vaccination for older adults where shingles is an important public health problem. Countries still set their own age, coverage and access rules, while recombinant vaccine requires a two-dose course.
Taiwan-based Repurgenesis said in late July 2026 that it had signed a memorandum of understanding with Switzerland-based Medvisis to pursue AI-assisted drug repurposing. The public announcement names a platform and a commercial network, but not a candidate, dataset, validation plan or binding development milestone.
The World Health Organization published an updated COVID-19 vaccine position paper on July 31, 2026, with recommendations organized by risk group and national context. A practical adult vaccine review starts with documented doses, then applies the age, pregnancy, health, work and travel rules used where care is received.
The World Health Organization's European office said on July 24, 2026, that adults should apply approved mosquito repellent to young children and keep it off their hands, eyes and mouth. Age limits differ among countries, so the locally authorized label must guide product choice and application.
The UK's medicines regulator announced stronger addiction, dependence, withdrawal and tolerance warnings for benzodiazepines and Z-drugs on January 8, 2026. It said abrupt cessation can trigger withdrawal and that tapering should be gradual, individualized and adjusted when symptoms become intolerable.
